Strong quarterly performance and a record order backlog have prompted Siemens to raise its full-year guidance, signaling robust operational health for the industrial conglomerate. However, this strength coincides with a significant strategic shift, including the planned separation of its healthcare unit, Siemens Healthineers.
Record Backlog Fuels Confidence
Siemens has kicked off its fiscal year with impressive momentum. The Munich-based company reported a 15% increase in industrial profit, reaching €2.9 billion for the first quarter of 2026. This growth was driven not merely by cost-saving initiatives but by genuine demand, with comparable order intake climbing by 10%.
A key indicator of future performance, the order backlog, has swelled to a historic €120 billion. This substantial pipeline provided management with the confidence to upgrade its earnings per share forecast. The new projected range is now between €10.70 and €11.10.
Artificial Intelligence: A Dual-Edged Sword
A primary catalyst for recent growth is the global surge in demand for data processing capacity. Revenue from data center infrastructure soared by 35%, fueled largely by major contracts from the United States. The company’s technological ambitions are further highlighted by its partnership with NVIDIA to develop AI-controlled factories, with the initial implementation starting at its facility in Erlangen.
Should investors sell immediately? Or is it worth buying Siemens?
Nevertheless, the AI boom presents a complex strategic landscape. Analysis from Bloomberg points to a potential long-term challenge: whether Siemens can capitalize on the AI wave without generative models undermining its own high-margin software business. This tension between being a hardware beneficiary and facing software disruption is likely to be a major factor in the stock’s long-term valuation.
Strategic Restructuring and Market Performance
Alongside its day-to-day operations, Siemens is advancing a major corporate simplification. The proposed spin-off of Siemens Healthineers is taking shape, with plans to distribute 30% of the shares directly to existing Siemens shareholders. The company is also returning capital to investors through other channels, including a planned dividend increase to €5.35 per share and the continued execution of its share buyback program.
The market has responded favorably to this strategy thus far. Currently trading around €248.40, the share price remains stable near its 50-day moving average. It maintains a healthy buffer of over 5% above its 200-day moving average of €235.12, preserving the broader upward trend despite a slight 0.30% dip at the start of today’s session.
Investor attention now turns to the upcoming quarterly report on May 13th. Key points of focus will be the finer details of the Healthineers deconsolidation and whether the explosive growth in the data center sector can be sustained.
Ad
Siemens Stock: Buy or Sell?! New Siemens Analysis from February 27 delivers the answer:
The latest Siemens figures speak for themselves: Urgent action needed for Siemens investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 27.
Siemens: Buy or sell? Read more here...
